Breaking News

OctoPlus Wins Drug Delivery Evaluation Contract

OctoPlus N.V. has signed a new drug delivery technology evaluation contract for two compounds with a European biotech company.

OctoPlus N.V. has signed a new drug delivery technology evaluation contract for two compounds with a European biotech company. Under the contract, OctoPlus will evaluate the feasibility of two controlled release formulations that combine the active ingredients of the client’s compounds with OctoPlus’ drug delivery technology. If the evaluations are successful, the contract may progress to a full process development, manufacturing and licensing agreement.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters